BrightSpring jumps after Q1 beat and higher 2026 revenue, EBITDA guidance
BrightSpring Health Services shares rose after the company reported Q1 2026 results that beat expectations and raised its full-year 2026 outlook. The company posted $3.61B revenue and $0.39 adjusted EPS, and lifted 2026 revenue and adjusted EBITDA guidance ranges.
1. What’s moving the stock
BrightSpring Health Services (BTSG) is moving higher today after reporting first-quarter 2026 financial results that topped expectations and came with increased full-year 2026 guidance. The combination of a quarterly beat and a higher outlook is driving renewed buying interest as investors reprice the company’s earnings power for the rest of 2026. (globenewswire.com)
2. The key numbers behind the jump
For Q1 2026, BrightSpring reported revenue of about $3.61 billion and adjusted EPS of $0.39, exceeding consensus estimates cited in early trading coverage. Adjusted EBITDA was reported at about $190 million, reflecting sharp year-over-year growth and improving operating leverage. (investing.com)
3. Guidance raised, adding fuel to the move
BrightSpring increased its full-year 2026 guidance, lifting revenue to $14.725 billion–$15.225 billion and adjusted EBITDA to $795 million–$825 million, putting both midpoints above prior expectations referenced in market coverage. Investors are reacting most to the raised outlook because it suggests the Q1 momentum can carry through the year. (investing.com)
4. Additional context investors are weighing today
The company also highlighted capital allocation actions and balance-sheet progress, including a $60 million share repurchase completed during the quarter and improved leverage metrics as of March 31, 2026. Separately, BrightSpring completed the divestiture of its Community Living business to Sevita on March 30, 2026, which the market may view as sharpening focus on the core segments. (investing.com)